2024
Maternal and Newborn Outcomes of SARS-CoV-2/COVID-19 and Pregnancy: Parallels and Contrasts with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
Li D, Zhang J, Zhang X, Chang Y, Vermund S. Maternal and Newborn Outcomes of SARS-CoV-2/COVID-19 and Pregnancy: Parallels and Contrasts with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome. Medical Research Archives 2024, 12: 10.18103/mra.v12i4.5205. PMID: 39118854, PMCID: PMC11309002, DOI: 10.18103/mra.v12i4.5205.Peer-Reviewed Original ResearchHuman immunodeficiency virus/acquired immunodeficiency syndromeHuman immunodeficiency virusHuman immunodeficiency virus-infected womenAdherence to antiretroviral therapyNeonatal outcomesImmunodeficiency virusImmunodeficiency syndromeIntensive care unitAntiretroviral therapySARS-CoV-2Maternal mortalityRisk of mother-to-child transmissionVertical transmissionVertical transmission of human immunodeficiency virusClinical managementTransmission of human immunodeficiency virusImpact of human immunodeficiency virusIncreased risk of maternal mortalityHuman immunodeficiency virus controlPoor adherence to antiretroviral therapySARS-CoV-2 vertical transmissionVertical transmission of SARS-CoV-2Pregnant individualsMother-to-child transmissionNeonatal intensive care unit
2023
Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults
Kopel H, Nguyen V, Boileau C, Bogdanov A, Winer I, Ducruet T, Zeng N, Bonafede M, Esposito D, Martin D, Rosen A, Van de Velde N, Vermund S, Gravenstein S, Mansi J. Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults. Vaccines 2023, 11: 1711. PMID: 38006043, PMCID: PMC10675676, DOI: 10.3390/vaccines11111711.Peer-Reviewed Original ResearchCOVID-19-related hospitalizationRelative vaccine effectivenessOutpatient visitsPrimary care electronic health recordsCOVID-19-related outcomesVaccine-induced protectionMedical claims dataCOVID-19 vaccineSARS-CoV-2Electronic health recordsVaccine effectivenessVaccine recipientsMRNA vaccinesBivalent vaccineBaseline differencesStudy populationClaims dataOmicron variantComparative effectivenessHospitalizationPropensity scoreVaccineOlder adultsHealth recordsVisitsPopulation-Level Effectiveness of an Inactivated Whole-Virion COVID-19 Vaccine: A Test Negative Case-Control Study in the Dominican Republic
Pérez-Then E, Miric M, Qian H, Chen Y, Wang Y, Vallejo V, Quezada W, Flaquer M, Olivo J, Castillo J, García N, Calderón K, Cueto S, Veras B, Russo M, Jiménez I, Guzmán S, Garabito L, Cueto E, Colombo F, Taveras D, Torres D, Baez J, Yunen J, Koenig E, Pérez E, López O, Medina F, Wang X, Shao Y, Vermund S, Díaz G, Severino F, Acevedo A, Luciano J, Cuello J, Acevedo I, Espinál M, Martínez C, Díaz D, Espinál D, Almonte D, Rodríguez J, Rosa J, Reyes J, Fernández J, De Jesús Marte Mercado M, De Los Santos Carmona R, Liriano R, Heyliger A, Mejía A, Turbis A, Aquino C, José E, Del Rosario Y, Rosario C, Hermón J, Colón A, Flores A, Díaz C, Rodríguez D, Estrella J, Colón J, Reyes J, Gil L, Abbott M, de Mota M, Polanco N, Jiménez I, Santana R, Herrera S, Castellanos A, Germosén A, Fajardo F, Mercedes K, Méndez M, F S, Sánchez T, Payano Y, Gómez Y, Mejía Y, Sánchez D, Infante H, Grullón M, Lemos Y, Carpio P, Pineda C, Núñez M, Espiritusanto D, Álvarez G, Nina G, Cabrera K, Guerrero R, Mejía B, Nicolás K, Guante M, Lebrón M, Bidó M, Monción M, Brito E, Rosado S, de apoyo P, de Sosa A, Pimentel B, Feliciano D, de los Santos L, Morillo M, Mateo P, de la Cruz R, de los Ángeles García M, Tavárez Y, Luna R, Castillo Y, Ulloa E, Pérez E. Population-Level Effectiveness of an Inactivated Whole-Virion COVID-19 Vaccine: A Test Negative Case-Control Study in the Dominican Republic. Open Forum Infectious Diseases 2023, 10: ofad075. PMID: 36998630, PMCID: PMC10043129, DOI: 10.1093/ofid/ofad075.Peer-Reviewed Original ResearchSymptomatic SARS-CoV-2 infectionTest-negative case-control studyCOVID-19-related hospitalizationSARS-CoV-2 infectionCase-control studyCOVID-19 vaccineFull vaccinationAssisted ventilationPartial vaccinationLower oddsAcute respiratory syndrome coronavirus 2 infectionCoronavirus disease 2019 (COVID-19) vaccination programsInactivated COVID-19 vaccineNegative case-control studySyndrome coronavirus 2 infectionPositive polymerase chain reaction testCOVID-19-related symptomsNationwide vaccination campaignPCR-positive participantsCoronavirus 2 infectionReal-world effectivenessPolymerase chain reaction testPopulation-level effectivenessSARS-CoV-2Chain reaction test
2022
Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis
Deng L, Li P, Zhang X, Jiang Q, Turner D, Zhou C, Gao Y, Qian F, Zhang C, Lu H, Zou H, Vermund S, Qian H. Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis. Scientific Reports 2022, 12: 20763. PMID: 36456577, PMCID: PMC9714387, DOI: 10.1038/s41598-022-24220-7.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 reinfectionSystematic reviewReinfection incidenceHazard ratioCase reportIncidence ratePrior SARS-CoV-2 infectionSARS-CoV-2 infectionIncidence of reinfectionInfection-naïve individualsRisk of reinfectionSARS-CoV-2 variantsRandom-effects modelSARS-CoV-2Web of ScienceCohort studyReinfection riskReinfection casesPrior infectionLower riskNew infectionsOmicron variantReinfectionInfection incidenceIncidenceCOVID-19 Clinical Presentation Among HIV-Infected Persons in China: A Systematic Review
Huang D, Zunong J, Li M, Li D, Gong J, Vermund SH, Hu Y. COVID-19 Clinical Presentation Among HIV-Infected Persons in China: A Systematic Review. Current HIV/AIDS Reports 2022, 19: 167-176. PMID: 35394249, PMCID: PMC8990500, DOI: 10.1007/s11904-022-00606-0.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyCOVID-19 clinical severityCOVID-19 clinical presentationCOVID-19Undetectable viral loadAsymptomatic COVID-19Severe COVID-19Last clinical visitCase series/reportsCase fatality rateCOVID-19 prognosisLate antiretroviral therapyIL-6 resultsSARS-CoV-2COVID-19 diagnosisMedian CD4Gastrointestinal symptomsHIV infectionMedian ageRespiratory distressClinical featuresClinical presentationClinical visitsViral loadClinical detailsIntersecting Pandemics of HIV and SARS-CoV-2: Commentary on the Special Issue
Vermund SH. Intersecting Pandemics of HIV and SARS-CoV-2: Commentary on the Special Issue. Current HIV/AIDS Reports 2022, 19: 1-4. PMID: 35192108, PMCID: PMC8862004, DOI: 10.1007/s11904-022-00599-w.Peer-Reviewed Original Research
2020
How coronavirus disease 2019 entered Africa and the Middle East: a case study from Egypt
Khattab NM, Vermund SH, Hu Y. How coronavirus disease 2019 entered Africa and the Middle East: a case study from Egypt. Transactions Of The Royal Society Of Tropical Medicine And Hygiene 2020, 114: 715-717. PMID: 32785588, PMCID: PMC7454931, DOI: 10.1093/trstmh/traa065.Peer-Reviewed Original ResearchCoinfection With HIV and SARS-CoV-2 in Wuhan, China: A 12-Person Case Series
Hu Y, Ma J, Huang H, Vermund SH. Coinfection With HIV and SARS-CoV-2 in Wuhan, China: A 12-Person Case Series. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2020, 85: 10.1097/qai.0000000000002424. PMID: 32568771, PMCID: PMC7446977, DOI: 10.1097/qai.0000000000002424.Peer-Reviewed Original ResearchConceptsAntiretroviral therapySARS-CoV-2Clinical improvementCase seriesLong-term antiretroviral therapyMild COVID-19 symptomsCOVID-19 coinfectionAcute COVID-19COVID-19 symptomsYears of ageCOVID-19Health care servicesPossible COVID-19 casesCoinfected PersonsAntiretroviral medicationsMedian ageIntensive careCOVID-19 casesClinical prognosisFavorable outcomeSevere symptomsAdditional casesCare servicesHIVInformed consent